Blockade, genetic deletion of IL-22, or blockade of CXCR2, the common ligand for the CXC family of neutrophil-active chemokines, significantly attenuated disease in the TRUC model of chronic colitis. The gene discussed is IL22; the disease is Chronic colitis.